Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 19, 2024

Primary Completion Date

July 15, 2026

Study Completion Date

July 15, 2026

Conditions
Breast Cancer
Interventions
BEHAVIORAL

Intermittent Fasting

"Participants will be asked to adhere to a six-month intermittent fasting intervention, a daily-recurring dietary plan consisting of:~* An approximately fourteen-hour nightly fasting period that is followed by~* An approximately ten-hour eating period with their last meal of the day occurring between 17:00 (5:00 PM) and 21:00 (9:00 PM)."

Trial Locations (1)

53226

RECRUITING

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER